Stay updated on Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.

Latest updates to the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page
- Check2 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has undergone significant content changes, particularly the removal of detailed information regarding a Phase II study on crenezumab for Alzheimer's disease, including participant criteria and study specifics, while a new revision number has been added.SummaryDifference24%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check60 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.